SCHEMBL19206798

SCHEMBL19206798

COc1cc(C)c(OS(=O)(=O)C(F)(F)F)c(C=O)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 2/20 0.36
ALDH1A1 P00352 5/20 0.34
TRIM24 O15164 1/20 0.33
TYR P14679 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
PRKDC P78527 1/20 0.32
KDM4E B2RXH2 2/20 0.31
KMT2A Q03164 1/20 0.31
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CYP19A1 P11511 1/20 0.31
NQO2 P16083 1/20 0.31
PTPN1 P18031 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CYP1A1 P04798 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18795482 0.84 ERN1 (0.36) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL5659758 0.80 MAPT (0.43) ERN1ALDH1A1PRKDCKDM4EKMT2A
SCHEMBL10023122 0.78 ERN1 (0.47) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL19760898 0.78 SRC (0.32) ALDH1A1TSHRCA1CA2
SCHEMBL19717108 0.77 ERN1 (0.49) ERN1ALDH1A1PRKDCKDM4ETSHR
SCHEMBL10020233 0.75 ALDH1A1 (0.49) ERN1ALDH1A1TRIM24TYRTRIM33
SCHEMBL671574 0.75 SRC (0.45)
SCHEMBL1252245 0.75 CXCR2 (0.34) CA1CA2MAPT
SCHEMBL16362230 0.74 ALDH1A1 (0.41) ALDH1A1TRIM24TRIM33KDM4ETSHR
SCHEMBL4730537 0.74 CYP1A1 (0.47) ALDH1A1KDM4EKMT2ACYP19A1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12012466-B2 Peptide macrocycles against Acinetobacter baumannii HOFFMANN-LA ROCHE INC. (US) 2024-06-18 US disclosed
US-20220411468-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN-LA ROCHE INC. (US) 2022-12-29 US disclosed
CN-108350028-B Peptide macrocycles against Acinetobacter baumannii 豪夫迈·罗氏有限公司 2021-12-07 CN disclosed
EP-3368544-B1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN LA ROCHE (CH) 2020-06-17 EP disclosed
US-20180362578-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN-LA ROCHE INC. (US) 2018-12-20 US disclosed
US-10030047-B2 Peptide macrocycles against acinetobacter baumannii HOFFMANN-LA ROCHE INC. (US) 2018-07-24 US disclosed
US-20170233437-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII HOFFMANN-LA ROCHE INC. (US) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411468-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII VIP, ARG1, CX3CR1 ERN1 2560/4885ALDH1A1 4290/4885TRIM24 1373/4885
US-12012466-B2 Peptide macrocycles against Acinetobacter baumannii VIP, ARG1, CX3CR1 ERN1 2560/4885ALDH1A1 4290/4885TRIM24 1373/4885
US-20180362578-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII VIP, ARG1, CX3CR1 ERN1 2560/4885ALDH1A1 4290/4885TRIM24 1373/4885
US-20170233437-A1 PEPTIDE MACROCYCLES AGAINST ACINETOBACTER BAUMANNII VIP, ARG1, CX3CR1 ERN1 2560/4885ALDH1A1 4290/4885TRIM24 1373/4885
US-10030047-B2 Peptide macrocycles against acinetobacter baumannii VIP, ARG1, CX3CR1 ERN1 2560/4885ALDH1A1 4290/4885TRIM24 1373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.